跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CD7-CAR-T
首页
药物
CD7-CAR-T
CD7-CAR-T
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Universal CAR-T cell targeting CD7
申请人: SHANGHAI YOUTI JISHENG BIOLOGICAL MEDICINE CO LTD
优先权: 2022
CN
Preparation method of CAR-T cell targeting CD7
申请人: SUZHOU DANLUO PHARMACEUTICAL CO LTD
优先权: 2023
CN
CD7-CAR-T cell and preparation and application thereof
申请人: PERSONGEN BIOMEDICINE SUZHOU CO LTD
优先权: 2019
CN
3 件公开
Universal CAR-T targeting CD5 and CD7 and application thereof
申请人: SHANGHAI XUNLU BIO TECH CO LTD
优先权: 2022
CN
2 件公开
CD7-CAR-T CELL, ITS PREPARATION METHOD AND THE APPLICATION THEREOF
申请人: XU ZHONGWEI
优先权: 2022
CN
US
2 件公开
CD7 and FAS double-gene knockout CD7 CAR-T cell as well as preparation method and application thereof
申请人: UNIV SOUTHERN SCI & TECH
优先权: 2025
CN
Bispecific universal CAR-T cell capable of simultaneously targeting CD7 and CD19 and preparation method of bispecific universal CAR-T cell
申请人: XIAN MULBERRY NISI CELL BIOMEDICINE CO LTD
优先权: 2021
CN
一种CD7-CAR-T细胞的制备方法及应用
申请人: 博生吉医药科技(苏州)有限公司
优先权: 2020
CN
药物
反馈